Cargando…
Protection against Experimental Melioidosis following Immunisation with a Lipopolysaccharide-Protein Conjugate
Melioidosis is a severe infectious disease caused by Burkholderia pseudomallei. It is refractory to antibiotic treatment and there is currently no licensed vaccine. In this report we detail the construction and protective efficacy of a polysaccharide-protein conjugate composed of B. pseudomallei lip...
Autores principales: | Scott, Andrew E., Ngugi, Sarah A., Laws, Thomas R., Corser, David, Lonsdale, Claire L., D'Elia, Riccardo V., Titball, Richard W., Williamson, E. Diane, Atkins, Timothy P., Prior, Joann L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033506/ https://www.ncbi.nlm.nih.gov/pubmed/24892035 http://dx.doi.org/10.1155/2014/392170 |
Ejemplares similares
-
Protection against Experimental Melioidosis with a
Synthetic manno-Heptopyranose Hexasaccharide Glycoconjugate
por: Scott, Andrew E., et al.
Publicado: (2016) -
Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis
por: Cuccui, Jon, et al.
Publicado: (2013) -
The lymphatic system as a potential mechanism of spread of melioidosis following ingestion of Burkholderia pseudomallei
por: Nelson, Michelle, et al.
Publicado: (2021) -
Assessment of CD200R Activation in Combination with Doxycycline in a Model of Melioidosis
por: Thom, R. E., et al.
Publicado: (2023) -
Efficacy of Co-Trimoxazole against Experimental Melioidosis Acquired by Different Routes of Infection
por: Nelson, Michelle, et al.
Publicado: (2022)